A method for easily and highly purifying exogenous proteins expressed in egg white
The method uses oviduct-specific gene promoters and affinity chromatography to purify exogenous proteins in egg white with high purity and yield, addressing interference issues and maintaining protein activity and egg production.
Patent Information
- Application Number
- JP2020147021
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2020-09-01
- Publication Date
- 2024-11-07
- Estimated Expiration
- 2040-09-01
AI Technical Summary
Existing methods struggle to purify exogenous proteins expressed in egg white with high purity and yield using egg bioreactor technology, as they often interfere with protein activity and egg production, and suitable affinity tags are not identified.
A method involving affinity chromatography using oviduct-specific gene promoters to express proteins with affinity tags, such as histidine or FLAG tags, followed by purification with nickel or anti-FLAG antibody-supported carriers, optionally preceded by ammonium sulfate salting out.
Enables high-purity and high-yield purification of exogenous proteins like cytokines and immunoglobulins from egg white, maintaining protein activity and reducing egg production disruptions.
Smart Images

Figure 0007578944000002 
Figure 0007578944000003 
Figure 0007578944000004
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for purifying a protein, and more particularly to a method for purifying an exogenous protein expressed in the egg white of a poultry egg in a simple manner with high purity and high yield. [Background technology]
[0002] A technology (egg bioreactor technology) has been developed to mass-produce a target exogenous protein in the egg white of poultry eggs (Patent Document 1, Non-Patent Document 1). This technology involves knocking in an exogenous gene encoding a target protein under the control of an oviduct-specific gene promoter to obtain a knock-in poultry, and then recovering the target protein produced in the egg white of poultry eggs. Using this technology, useful proteins such as interferon β and immunoglobulins can be produced at high concentrations of 1 mg or more per egg. However, since egg white contains a large number of diverse proteins, it is difficult to purify the target exogenous protein. [Prior art documents] [Patent documents]
[0003] [Patent Document 1] International Publication WO2017 / 111144 [Non-patent literature]
[0004] [Non-Patent Document 1] Oishi et al. Efficient production of human interferon beta in the white of eggs from ovalbumin gene-targeted hens. Sci. Rep. 2018 Summary of the Invention [Problem to be solved by the invention]
[0005] In protein expression systems using microorganisms or cultured animal cells, one of the means for easily and highly purifying a target protein is to express the target protein in a form with an affinity tag such as a histidine tag, glutathione-S-transferase (GST), maltose-binding protein, HA tag, myc tag, FLAG tag, or Fc fragment of the IgG heavy chain, and purify it using affinity chromatography or affinity beads. However, when an exogenous protein is expressed in egg white using chicken egg bioreactor technology, it is not always possible to express the target protein easily and purify it to a high degree of purity in the same way as when using microorganisms or animal cells.
[0006] In addition, when expressing an affinity-tagged protein in egg white, the type of affinity tag used may have undesirable effects on the activity and properties of the protein, egg properties, egg number, etc. Therefore, it was important to find an affinity tag that is suitable for egg bioreactors.
[0007] Under these circumstances, there has been a demand for a method for purifying a target exogenous protein simply, with high purity and in high yield, from the egg white of poultry eggs obtained using egg bioreactor technology, including investigation of affinity tags. [Means for solving the problem]
[0008] The present inventors have conducted extensive research to solve the above problems, and have obtained poultry in which a gene encoding an exogenous protein with an affinity tag has been knocked in, and have been able to obtain eggs containing the exogenous protein of interest from the poultry. They then attempted to purify the protein of interest from the egg white using affinity chromatography, and found that the exogenous protein of interest could be purified easily with high purity and high yield, thereby completing the present invention.
[0009] That is, the present invention provides the following: (1) A method for preparing an exogenous protein from poultry eggs, comprising the steps of: (a) subjecting poultry egg whites to affinity chromatography; and (b) collecting fractions containing the exogenous protein; wherein the poultry is a knock-in poultry, in which a gene encoding an exogenous protein with an affinity tag has been knocked in under the control of an oviduct-specific gene promoter. (2) The method described in (1), wherein the fallopian tube-specific gene promoter is a promoter of at least one fallopian tube-specific gene selected from the group consisting of ovalbumin, ovomucoid, ovomucin, ovotransferrin, ovoinhibitor and lysozyme. (3) The method described in (2), wherein the fallopian tube-specific gene promoter is an ovalbumin gene promoter and a gene encoding an exogenous protein with an affinity tag is inserted into exon 2 of the ovalbumin gene. (4) The method according to any one of (1) to (3), wherein the gene encoding an exogenous protein is a gene encoding a cytokine, an immunoglobulin, a collagen, or an immunoglobulin-specific protein. (5) The method according to any one of (1) to (4), wherein the affinity tag is selected from the group consisting of a histidine tag, a maltose binding protein, an HA tag, a myc tag, a FLAG tag, and an Fc fragment of the IgG heavy chain. (6) The method described in (5), wherein the affinity tag is a histidine tag or a FLAG tag. (7) The method described in (6), wherein the affinity tag is a histidine tag, the histidine tag is attached to the N-terminus or C-terminus of the exogenous protein, and the affinity chromatography uses a nickel-loaded carrier. (8) The method according to (6), wherein the affinity tag is a FLAG tag, the FLAG tag is attached to the N-terminus or C-terminus of the exogenous protein, and the affinity chromatography uses an anti-FLAG antibody-carrying carrier. (9) The method according to any one of (1) to (8), which comprises carrying out ammonium sulfate precipitation before carrying out affinity chromatography. Effect of the Invention
[0010] By using the method of the present invention, a target protein can be easily purified with high purity and high yield from the egg white of poultry eggs obtained by the egg bioreactor technology only through an affinity chromatography step. Therefore, the present invention will greatly contribute to the mass production of useful proteins such as cytokines, immunoglobulins, and protein A / G using the egg bioreactor technology. [Brief description of the drawings]
[0011] [Figure 1] Figure 1 shows SDS-PAGE of human interleukin-4 (IL-4) purified using a nickel column from egg white of a chicken in which histidine-tagged human IL-4 was knocked in as an exogenous protein. In the figure, Input is unpurified egg white, FT is the purification residue, Wash1 and Wash2 are the first and second washing solutions with a 20 mM imidazole-containing buffer, respectively, Elute1-6 are the first to sixth eluates with a 250 mM imidazole-containing buffer, and x10 is a 10-fold concentration of each eluate. [Diagram 2] FIG. 2 is a graph showing the results of comparing the activities of human IL-4 and human granulocyte monocyte colony-stimulating factor (GMCSF) purified through a nickel column with the activities of commercially available products. [Diagram 3]Figure 3 shows SDS-PAGE results of human interleukin-4 (IL-4) purified from egg white of a chicken in which FLAG-tagged human IL-4 was knocked in as an exogenous protein, using anti-FLAG antibody-bound beads (Cosmo Bio Co., Ltd. product name: Anti DYKDDDDK FLAG). In the figure, Input is unpurified egg white, FT is purification residue, Elute1-4 are the first to fourth eluates with 100 mM glycine-HCl (pH 3.0), beads are the eluates of proteins remaining on the beads after the purification was completed for confirmation, and x3 is each eluate concentrated 3 times. [Figure 4] 4 is a graph showing the number of eggs laid, the number of normal eggs, and the number of shellless eggs for 100 days after the first egg laying in chickens knocked in with a gene encoding a GST-tagged protein of human GMCSF at the N-terminus (GST-GMCSF), a gene encoding a FLAG-tagged and histidine-tagged protein of human GMCSF at the N-terminus and C-terminus, respectively (FLAG-GMCSF-His), and untagged human GMCSF (Wild Type). The height of the bar indicates the number of eggs laid, the number above the bar indicates the number of shellless eggs, and the number below indicates the number of normal eggs. [Diagram 5] 5 shows an SDS-PAGE image of the ammonium sulfate precipitate of egg white expressing histidine-tagged IL-4. In the figure, 0% ppt means a fraction with no ammonium sulfate added, 30% ppt means a 0% to 30% saturated ammonium sulfate fraction, 40% ppt means a 30% to 40% saturated ammonium sulfate fraction, 50% ppt means a 40% to 50% saturated ammonium sulfate fraction, 60% ppt means a 50% to 60% saturated ammonium sulfate fraction, 70% ppt means a 60% to 70% saturated ammonium sulfate fraction, and 80% ppt means a 70% to 80% saturated ammonium sulfate fraction. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0012] The present invention relates to 1. A method for preparing an exogenous protein from poultry eggs, comprising the steps of: (a) subjecting poultry egg whites to affinity chromatography; and (b) collecting fractions containing the exogenous protein; wherein the poultry is a knock-in poultry, in which a gene encoding an exogenous protein with an affinity tag has been knocked in under the control of an oviduct-specific gene promoter.
[0013] The above method is a method for purifying an exogenous protein in the egg white of a poultry egg obtained by the chicken egg bioreactor technology. The chicken egg bioreactor technology is outlined as follows. A gene encoding an exogenous protein is knocked in under the control of an oviduct-specific gene promoter by modifying the genes of poultry primordial germ cells (for example, by using genome editing), and a knock-in female poultry derived from the genetically modified primordial germ cells is obtained, and an egg is obtained from this female. A large amount of the exogenous protein of interest is produced in the egg white of this egg. For details of the chicken egg bioreactor technology, see International Publication No. WO2017 / 111144. The entire contents of International Publication No. WO2017 / 111144 are incorporated herein by reference.
[0014] Poultry include, but are not limited to, chickens, quail, turkeys, ducks, geese, cockroaches, bantams, pigeons, ostriches, pheasants, guinea fowl, etc. Preferred poultry are chickens, quails, etc.
[0015] A gene encoding an affinity tag is added to a gene encoding an exogenous protein to knock it in. Methods for adding a gene encoding an affinity tag to a gene encoding an exogenous protein are known, and gene recombination techniques are generally used. An exogenous protein with an affinity tag is expressed and produced in the egg white of poultry eggs obtained using a chicken egg bioreactor. The affinity tag can be used to purify the target exogenous protein in the egg white.
[0016] An exogenous protein refers to a protein that is not expressed in the poultry to be knocked in. The exogenous protein may be of any type. The species of origin of the exogenous protein is not particularly limited, and may be an animal, a plant, a microorganism, a virus, or the like. In this specification, the exogenous protein includes not only a protein, but also a protein fragment, a peptide, and an oligopeptide. The exogenous protein may be a wild type or a mutant type. The mutant type of the exogenous protein may be a natural mutation or may be an artificially produced one.
[0017] Examples of exogenous proteins include, but are not limited to, cytokines, enzymes, hormones, growth factors, collagen, serum albumin, extracellular matrix molecules, antibodies and fragments thereof (e.g., Fv, scFv, dsFv, Fab, Fab', F(ab')2, single chain antibodies, etc.), immunoglobulin-specific proteins, vaccines, agonistic proteins, antagonistic proteins, etc. Examples of cytokines include, but are not limited to, interferons, interleukins, chemokines, lymphokines, and tumor necrosis factors, etc. Examples of immunoglobulin-specific proteins include, but are not limited to, protein A, protein G, protein L, etc.
[0018] A gene encoding an exogenous protein is knocked in under the control of an oviduct-specific gene promoter. This is preferable because it allows for the production of eggs containing the protein encoded by the exogenous gene instead of the expression metabolite of the oviduct-specific gene. Examples of oviduct-specific genes include, but are not limited to, genes such as ovalbumin, ovomucoid, ovomucin, ovotransferrin, ovoinhibitor, and lysozyme. Depending on the type of exogenous protein, the oviduct-specific gene can be selected. A typical example of an oviduct-specific gene is the ovalbumin gene. Preferably, the gene encoding the exogenous protein is inserted into exon 2 of the ovalbumin gene, but the insertion site is not limited to exon 2. The gene encoding the exogenous protein to be knocked in may be one type, or two or more types. The genotype of the knock-in poultry may be homozygous or heterozygous.
[0019] "Under the control of the oviduct-specific gene promoter" refers to the gene region that is affected by the promoter of the oviduct-specific gene. More specifically, by inserting the nucleotide sequence encoding an exogenous protein under the control of the oviduct-specific gene promoter by knock-in, the exogenous protein is expressed in the oviduct by the action of the oviduct-specific gene promoter. In this case, the 5' side of the nucleotide sequence encoding the exogenous protein may contain a basic sequence related to transcription, such as a Kozak sequence or a TATA sequence.
[0020] Various affinity tags are known. Purification methods for affinity-tagged proteins are also known. In general, exogenous proteins are purified using a column packed with a resin on which an antibody or ligand for the affinity tag to be used is immobilized. The affinity tag used in the present invention is a protein or peptide. In the present invention, the affinity tag is expressed in a form bound to the exogenous protein. The affinity tag may be added to the N-terminus, C-terminus, or within the amino acid sequence of the exogenous protein. Usually, the affinity tag is added to the N-terminus or C-terminus of the exogenous protein. The affinity tag can be appropriately selected depending on the type of exogenous protein, its purification conditions, the type of oviduct-specific gene, and the like. Examples of affinity tags include, but are not limited to, histidine tag, glutathione-S-transferase (GST), maltose-binding protein, HA tag, myc tag, FLAG tag, and Fc fragment of the H chain of IgG. Examples of preferred affinity tags include, but are not limited to, histidine tags and FLAG tags.
[0021] It is preferable to subject the poultry egg white to crude purification before subjecting it to affinity chromatography. The crude purification is generally performed by a precipitation method using a salt such as ammonium sulfate, a polymer such as polyethylene glycol, an acid such as trichloroacetic acid, or an organic solvent such as acetone, but other methods may also be used. The crude purification is preferably performed by ammonium sulfate salting out. By performing the crude purification, it is possible to increase throughput by increasing not only the purity but also the concentration.
[0022] Unless otherwise specified, the terms used in this specification are to be interpreted as having the meanings commonly understood in the fields of biology, biochemistry, chemistry, pharmacology, medicine, animal husbandry, and the like.
[0023] The present invention will be described in more detail and specifically below by showing examples, but the examples should not be construed as limiting the scope of the present invention. EXAMPLES
[0024] By utilizing a histidine tag, we established a method for easily and highly pure purification of exogenous proteins expressed in egg white.
[0025] Human IL-4, human GMCSF, and canine IL-4, known cytokines, were expressed in egg white from chicken eggs and purified efficiently using a nickel column. The proteins were expressed with a histidine tag at the C-terminus.
[0026] Exogenous genes containing a stop codon (encoding human IL-4, human GMCSF, and canine IL-4, each with a histidine tag added to the C-terminus) were knocked in to exon 2 of the ovalbumin gene in chicken primordial germ cells. The primordial germ cells containing the knocked-in cells were transplanted into recipient embryos and hatched to obtain male chimeric chickens. The male chimeric chickens were mated with female wild-type chickens to obtain progeny female chickens in which the above exogenous genes were knocked in to the ovalbumin locus. The eggs laid by the progeny female chickens thus obtained were used in the following experiments.
[0027] The purification procedure using nickel beads was carried out by a conventional method. 1.7 mL of egg white was diluted to 5 mL with sodium phosphate buffer (pH 8.0) containing 10 mM imidazole and sodium chloride, and the centrifuged supernatant was used for purification. The egg white supernatant was adsorbed onto a column packed with 0.75 mL of nickel beads (Cosmo Bio Co., Ltd., product number AC-310-25, 25 mL), and the nickel beads were washed four times with the same buffer except that the imidazole was increased to 20 mM. Then, 0.5 mL of the same buffer except that the imidazole was increased to 250 mM was added to elute and recover the adsorbed protein. The elution procedure was repeated six times.
[0028] The egg white (input), purification residue (FT), and nickel bead washing solution (Elute1-6, Elute1-6 x10) (x10 is 10-fold concentrated) used in the purification were subjected to SDS-PAGE (Figure 1). No bands of exogenous proteins contained in egg white were observed in the purification residue. In addition, no bands other than human IL-4 and non-glycosylated human IL-4 were observed in the eluate lane. These results confirmed that human IL-4 was recovered in high purity in the eluate. The protein concentration of the eluate was measured by the Bradford method, and 4.7 mg of protein was recovered in total from the six fractions (Table 1). The volume of egg white in a chicken egg is generally about 30 mL, and 1.7 mL was used this time, so it is considered that about 80 mg of human IL-4 was obtained from one chicken egg. The amount of human IL-4 in the chicken eggs was measured by ELISA and was found to be 90 to 140 mg / egg, so the recovery rate of the purification method of the present invention was evaluated to be very high. [Table 1]
[0029] Similar experiments were performed with human GMCSF and canine IL-4, and they were successfully purified with the same purity and recovery rate as human IL-4.
[0030] The activity of human IL-4 and GMCSF obtained by the above-mentioned methods was evaluated by a cell proliferation test (Figure 2). Purified human GMCSF showed a proliferation activity almost the same as that of the commercially available preparation. Purified human IL-4 retained cell proliferation activity, although it was lower than that of the commercially available preparation. It was confirmed that the activity can be maintained even when purified by the method of the present invention, although it varies depending on the type of exogenous protein. EXAMPLES
[0031] Human IL-4 was purified from egg white of a chicken in which an exogenous gene encoding human IL-4 with a FLAG tag added to the N-terminus was knocked in by the same method as above, using anti-FLAG antibody-bound beads (Cosmo Bio Co., Ltd., product name: Anti DYKDDDDK FLAG). Specifically, the experiment was performed as follows. 25 μL of egg white was diluted with ultrapure water to 1.25 mL and used for purification. The diluted egg white was adsorbed onto the anti-FLAG antibody-bound beads in a microtube, and the anti-FLAG antibody-bound beads were washed five times with sodium phosphate buffer (pH 8.0), and then 200 μL of 100 mM glycine-hydrochloric acid (pH 3.0) was added to elute and recover the adsorbed protein. The elution procedure was repeated four times.
[0032] The results are shown in Figure 3. In this experiment, no bands of exogenous proteins contained in the egg white (Input) were observed in the purification residue (FT). Furthermore, no bands other than human IL-4 and non-glycosylated human IL-4 were observed in the eluate lanes (Elute 1-4, Elute 1-4 x3, x3 was 3-fold concentrated). These results confirmed that human IL-4 was recovered in high purity in the eluate.
[0033] [Comparative Example] The number of eggs laid, normal eggs, and shellless eggs were examined for 100 days after the first egg laying in chickens that had been knocked in with a gene encoding a GST-tagged protein of human GMCSF at the N-terminus (GST-GMCSF), a gene encoding a FLAG-tagged and histidine-tagged protein of human GMCSF at the N-terminus and C-terminus, respectively (FLAG-GMCSF-His), and untagged human GMCSF (Wild Type). The results are shown in Figure 4.
[0034] The number of eggs laid by wild-type chickens was about 90, and the percentage of shell-free eggs was also low. The number of eggs laid by chickens with FLAG-GMCSF-His knocked-in was about 90, and the percentage of shell-free eggs was also low, which was similar to the results for wild-type chickens. On the other hand, the number of eggs laid by chickens with GST-GMCSF knocked-in was less than half that of the wild-type and FLAG-GMCSF-His knocked-in chickens, and most of the eggs were shell-free. These results demonstrated that the histidine tag and FLAG tag are suitable for egg bioreactors. EXAMPLES
[0035] We investigated ammonium sulfate precipitation as a pretreatment for affinity chromatography. Ammonium sulfate was added stepwise to a diluted sample of egg white expressing human IL-4 (0% saturation, 30% saturation, 40% saturation, 50% saturation, 60% saturation, 70% saturation, and 80% saturation) to precipitate the proteins. The proteins contained in each fraction were examined by SDS-PAGE. The results are shown in Figure 5.
[0036] The human IL-4 band was observed at around 25 kDa, and was abundant in the 40% ppt, 50% ppt, and 60% ppt fractions. Because the 60% ppt fraction contained a large amount of ovalbumin (around 45 kDa) and ovotransferrin (around 80 kDa), the 50% ppt fraction (40-50% saturated ammonium sulfate fraction) was used for purification by affinity chromatography. By performing crude purification by ammonium sulfate precipitation, it was possible to increase not only the purity but also the throughput by increasing the concentration. [Industrial Applicability]
[0037] The present invention makes it possible to obtain a large amount of useful proteins with high purity from the egg white of poultry eggs obtained by the chicken egg bioreactor technology. Therefore, the present invention can be used in the production of pharmaceuticals such as peptide pharmaceuticals, antibody pharmaceuticals, and biopharmaceuticals.
Claims
1. 1. A method for preparing exogenous proteins from poultry eggs, comprising the steps of: (a) subjecting poultry egg whites to affinity chromatography; and (b) collecting fractions containing the exogenous protein; wherein the poultry is a knock-in poultry, in which a gene encoding an exogenous protein with an affinity tag has been knocked in under the control of an oviduct-specific gene promoter, the oviduct-specific gene promoter being a promoter of an ovalbumin gene, the gene encoding an exogenous protein with an affinity tag being inserted into exon 2 of the ovalbumin gene, and the affinity tag being a histidine tag or a FLAG tag.
2. 2. The method of claim 1, wherein the gene encoding an exogenous protein is a gene encoding a cytokine, an immunoglobulin, a collagen, or protein A, protein G, or protein L.
3. 3. The method according to claim 1 or 2, wherein the affinity tag is a histidine tag attached to the N-terminus or C-terminus of the exogenous protein, and the affinity chromatography uses a nickel-loaded carrier.
4. 3. The method according to claim 1 or 2, wherein the affinity tag is a FLAG tag, the FLAG tag is attached to the N-terminus or C-terminus of the exogenous protein, and the affinity chromatography is carried out using an anti-FLAG antibody-carrying carrier.
5. The method according to any one of claims 1 to 4, further comprising carrying out ammonium sulfate precipitation prior to carrying out affinity chromatography.
Citation Information
Patent Citations
Gene construct for expressing protein in poultry fallopian tube, and method for producing protein using the gene construct
JP2006262875A
Genetically-modified poultry egg
WO2017111144A1
